Rudolf Krska of the University of Natural Resources and Life Sciences (BOKU), in Vienna, Austria, has been awarded the biennial B.R.A.I.N award at the Biomin scientific conference held in Vancouver, Canada.
Rudolf Krska of the University of Natural Resources and Life Sciences (BOKU), in Vienna, Austria, has been awarded the biennial B.R.A.I.N award at the Biomin scientific conference held in Vancouver, Canada.
As of 2013, Krska is the most-cited author on the topic of mycotoxins in the past decade, and this enormous contribution was highlighted as a key reason for Krska winning the award by the selection committee.
“Dr. Krska is a high flier in the field of mycotoxins who is well-recognized for his expertise by his peers,” said Eva Maria Binder, Chief Research Officer at the Erber Group.
Further to Krska’s ongoing work as a research scientist, his 20+ year track record of working with the Biomin Research Centre, part of the Erber Group, on numerous projects also contributed to him receiving the honour.
Biomin Founder and President of the Supervisory Board of Erber Group, Erich Erber, remarked that Rudolf Krska “is one of the most outstanding scientists I have come across in
my life. When we met [for the] first time in 1994 to discuss a common project on mycotoxins we could not imagine
where we stand today.”
Krska received his award on the final day of the scientific conference at the 2016 World Nutrition Forum, which included the B.R.A.I.N trophy and a check for $10,000.
Exploring Metabolite Alteration from Age-Related Macular Degeneration with UHPLC-MS/MS
February 19th 2025Exploring the alterations in metabolites of wet age-related macular degeneration (wAMD), metabolomic analysis was performed on the aqueous humor of 30 patients with wAMD receiving anti-vascular endothelial growth factor (anti-VEGF) treatments and 20 controls, via ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS).
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.